Penserra Capital Management LLC decreased its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 20.4% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 7,684 shares of the healthcare conglomerate's stock after selling 1,975 shares during the quarter. Penserra Capital Management LLC's holdings in UnitedHealth Group were worth $4,024,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds also recently added to or reduced their stakes in UNH. Norges Bank purchased a new position in shares of UnitedHealth Group during the 4th quarter valued at approximately $6,375,744,000. GAMMA Investing LLC lifted its holdings in UnitedHealth Group by 56,142.1% in the 1st quarter. GAMMA Investing LLC now owns 8,295,153 shares of the healthcare conglomerate's stock valued at $4,344,586,000 after purchasing an additional 8,280,404 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its stake in UnitedHealth Group by 36.6% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 8,592,718 shares of the healthcare conglomerate's stock valued at $4,346,712,000 after acquiring an additional 2,301,010 shares in the last quarter. Northern Trust Corp lifted its position in UnitedHealth Group by 12.5% during the fourth quarter. Northern Trust Corp now owns 9,503,671 shares of the healthcare conglomerate's stock worth $4,807,527,000 after buying an additional 1,058,488 shares in the last quarter. Finally, Capital International Investors grew its holdings in shares of UnitedHealth Group by 6.2% in the fourth quarter. Capital International Investors now owns 15,616,007 shares of the healthcare conglomerate's stock valued at $7,899,905,000 after purchasing an additional 906,365 shares during the period. Institutional investors and hedge funds own 87.86% of the company's stock.
Analysts Set New Price Targets
A number of research firms have recently weighed in on UNH. Baird R W cut UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a report on Wednesday, June 11th. Wells Fargo & Company reaffirmed an "overweight" rating on shares of UnitedHealth Group in a report on Friday, June 6th. Deutsche Bank Aktiengesellschaft decreased their target price on UnitedHealth Group from $521.00 to $362.00 and set a "buy" rating for the company in a research report on Wednesday, May 14th. JPMorgan Chase & Co. increased their target price on shares of UnitedHealth Group from $405.00 to $418.00 and gave the stock an "overweight" rating in a research note on Friday, June 20th. Finally, Piper Sandler cut their price objective on shares of UnitedHealth Group from $552.00 to $353.00 and set an "overweight" rating for the company in a research report on Tuesday, June 3rd. One analyst has rated the stock with a sell rating, nine have given a hold rating and sixteen have given a buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $415.00.
Read Our Latest Analysis on UNH
Insider Activity at UnitedHealth Group
In other news, Director Kristen Gil purchased 3,700 shares of the stock in a transaction dated Thursday, May 15th. The shares were bought at an average cost of $271.17 per share, for a total transaction of $1,003,329.00. Following the transaction, the director owned 3,818 shares in the company, valued at $1,035,327.06. This trade represents a 3,135.59% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CFO John F. Rex acquired 17,175 shares of UnitedHealth Group stock in a transaction dated Friday, May 16th. The shares were acquired at an average price of $291.12 per share, with a total value of $4,999,986.00. Following the transaction, the chief financial officer owned 203,796 shares in the company, valued at approximately $59,329,091.52. This represents a 9.20% increase in their position. The disclosure for this purchase can be found here. In the last 90 days, insiders have purchased 109,408 shares of company stock valued at $31,607,768. Company insiders own 0.28% of the company's stock.
UnitedHealth Group Stock Down 1.8%
Shares of UnitedHealth Group stock traded down $5.62 during trading hours on Wednesday, hitting $302.08. 12,778,535 shares of the company's stock traded hands, compared to its average volume of 7,629,597. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.71. UnitedHealth Group Incorporated has a twelve month low of $248.88 and a twelve month high of $630.73. The stock has a 50 day simple moving average of $320.63 and a 200-day simple moving average of $444.69. The company has a market cap of $274.03 billion, a PE ratio of 12.65, a PEG ratio of 1.47 and a beta of 0.45.
UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.29% and a net margin of 5.39%. The firm had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. During the same quarter in the previous year, the business posted $6.91 EPS. Equities research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.
UnitedHealth Group Increases Dividend
The company also recently declared a quarterly dividend, which was paid on Tuesday, June 24th. Stockholders of record on Monday, June 16th were given a dividend of $2.21 per share. The ex-dividend date of this dividend was Monday, June 16th. This represents a $8.84 annualized dividend and a dividend yield of 2.93%. This is a positive change from UnitedHealth Group's previous quarterly dividend of $2.10. UnitedHealth Group's dividend payout ratio is currently 37.02%.
About UnitedHealth Group
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Articles
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
